Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline GRI Q1 2026 Earnings WiderThanExpected Loss Deepens as PreRevenue Biotech Faces Headwinds Centrus Energy LEU Q1 2026 Earnings Strong EPS Beat Amidst Minimal Revenue Disclosure ELV Q1 2026 Earnings Strong EPS Beat Driven by Operational Excellence Kenon Holdings Q2 2025 Earnings Positive EPS of 010 Amid Limited Disclosures